Abstracts Archive - Page 1208 of 2607 - ACR Meeting Abstracts

Abstract Number: 323 • 2018 ACR/ARHP Annual Meeting
Impact of Gains in Rheumatoid Arthritis Disease Activity Documentation on Outcomes over Time
Jing Li¹, Julie Gandrup¹, Laura Trupin¹, Zara Izadi², Jinoos Yazdany¹ and Gabriela Schmajuk³, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ³San Francisco VA Medical Center, San Francisco, CA
Background/Purpose: Despite significant interest in using health information technology (IT) to improve processes of care such as documentation of disease activity in RA, few studies…
Abstract Number: 324 • 2018 ACR/ARHP Annual Meeting
Three Health It Interventions Increased Documentation of RA Disease Activity Scores in an Academic Rheumatology Clinic: Results from an Interrupted Time Series Study
Julie Gandrup^1,2, Jing Li², Zara Izadi³, Milena Gianfrancesco², Torkell Ellingsen⁴, Jinoos Yazdany² and Gabriela Schmajuk^5,6, ¹Rheumatology, Odense University Hospital, Odense, Denmark, ²Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ³Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, ⁴Department of Rheumatology, Odense University Hospital, Odense, Denmark, ⁵San Francisco VA Medical Center, San Francisco, CA, ⁶Medicine/Rheumatology, University of California - San Francisco, San Francisco, CA
Background/Purpose: Regular assessment of disease activity is a fundamental part of high quality RA care. Customization of electronic health records (EHRs) can facilitate the systematic…
Abstract Number: 325 • 2018 ACR/ARHP Annual Meeting
A Comparison of RADAI5 and RAPID3 Disease Measures
Ryan Jessee, Amanda M. Eudy and Megan E. B. Clowse, Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC
Background/Purpose: Treat to target has been shown to improve outcomes in multiple rheumatology diseases although relies on accurate disease measures. Our academic clinic routinely measures…
Abstract Number: 326 • 2018 ACR/ARHP Annual Meeting
Implementation of a Treat-to-Target Quality Improvement Program for Rheumatoid Arthritis Management Using Real-Time Patient Reported Outcome Measures
Malka Forman¹, Cianna Leatherwood², Chang Xu¹, Eunji Ko¹, Bing Lu³, Maura D. Iversen⁴, Daniel Solomon² and Sonali Desai², ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ³Division of Rheumatology, Immunology and Allergy, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Changing clinical practice patterns and incorporation patient-reported outcome measures (PROMs) for disease activity assessment into routine workflow is challenging. We sought to integrate a…
Abstract Number: 327 • 2018 ACR/ARHP Annual Meeting
The Patient Global Assessment and Common Composite Disease Activity Measures Vary Minimally When Patients Reflect on Their Arthritis or Their Global Health: Results from the Canadian Early Arthritis Cohort Study
Vivian P. Bykerk¹, Orit Schieir², Marie-France Valois³, Edward C. Keystone⁴, Gilles Boire⁵, Janet E. Pope⁶, Diane Tin⁷, Carol Hitchon⁸, Carter Thorne⁹, Susan J. Bartlett¹⁰ and Boulos Haraoui¹¹, ¹Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, ²McGill University, Montreal, ON, Canada, ³McGill University, Montreal, QC, Canada, ⁴University of Toronto and Mount Sinai Hospital, Toronto, ON, Canada, ⁵Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, ⁶Department of Medicine, University of Western Ontario, London, ON, Canada, ⁷The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ⁸University of Manitoba, Winnipeg, MB, Canada, ⁹University of Toronto, Newmarket, ON, Canada, ¹⁰Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ¹¹Institut de Recherche en Rhumatologie de Montréal (IRRM), Montreal, QC, Canada
Background/Purpose: The patient global assessment (PtGA) is a core domain used in RA composite disease activity (CDA) measures for trials and treat-2-target paradigms. The PtGA…
Abstract Number: 328 • 2018 ACR/ARHP Annual Meeting
Implementation of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) Documentation in Systemic Lupus Erythematosus (SLE) Patients at an Academic Medical Center
Sarah H. Chung¹, Hsin-Hsuan Juo², Jenna Thomason¹ and Alison Bays³, ¹Division of Rheumatology, University of Washington, Seattle, WA, ²rheumatology, University of Washington, seattle, WA, ³Rheumatology, University of Washington, Seattle, WA
Background/Purpose: The 2008 European League Against Rheumatism (EULAR) Task Force on SLE management encourages the use of at least one of the SLE disease indices…
Abstract Number: 329 • 2018 ACR/ARHP Annual Meeting
Use of Inter-Professional Collaboration to Improve Adherence to American College of Rheumatology Recommendations for Use of Disease Activity Measures
Elisheva Weinberger¹, Douglas Einstadter² and Marina Magrey¹, ¹Rheumatology, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, ²Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH
Background/Purpose: “Treat to target” is the goal of therapy in the treatment of Rheumatoid Arthritis (RA) based on the 2015 American College of Rheumatology (ACR)…
Abstract Number: 330 • 2018 ACR/ARHP Annual Meeting
The IMPACT of a Referral Algorithm for Axial Spondyloarthritis: Four Month Follow-up in Patient Reported Outcomes
Maha Jamal¹, Amber Korver², Martijn Kuijper³, Deirisa Lopes Barreto¹, Frank van den Hoogen⁴, Cathelijne W. Y. Appels⁵, Anneke Spoorenberg⁶, Bart Koes⁷, Lonneke van Hoeven⁸, JMW Hazes⁹ and Angelique EAM Weel³, ¹Maasstad Hospital, Rotterdam, Netherlands, ²Erasmuc Medical Center, Rotterdam, Netherlands, ³Rheumatology, Maasstad Hospital, Rotterdam, Netherlands, ⁴Radboud Medical center, Nijmegen, Netherlands, ⁵Rheumatology, Amphia Hospital, Breda, Netherlands, ⁶Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, ⁷Erasmuc Medical center, Rotterdam, Netherlands, ⁸Erasmus Medical center, Rotterdam, Netherlands, ⁹Rheumatology, Erasmus MC, Rotterdam, Netherlands
Background/Purpose: A substantial amount of patients with chronic low back pain (CLBP) have axial spondyloarthritis (axSpA), but early recognition of these patients is difficult for…
Abstract Number: 331 • 2018 ACR/ARHP Annual Meeting
Development and Implementation of a Patient-Reported Outcomes Measurement Information System (MyRheum)
Chad Deal¹, Abby Abelson², Leonard H. Calabrese³, Greg Strnad⁴, Irene Katzan⁴ and M. Elaine Husni⁵, ¹Cleveland Clinic, Shaker Heights, OH, ²Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, ³Rheumatology, Cleveland Clinic, Cleveland, OH, ⁴Cleveland Clinic, Cleveland, OH, ⁵Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH
Background/Purpose: There is a growing recognition of the potential value for measuring patient-reported outcomes (PROs) in patients with rheumatologic conditions. PROs measured at point of…
Abstract Number: 332 • 2018 ACR/ARHP Annual Meeting
Components of Impaired Physical Function and Disability in a Non-Rheumatic Population. Normative Values of the Health Assessment Questionnaire Disability Index
C Alejandro Arce-Salinas¹, H FABRICIO ESPINOSA-ORTEGA² and Olivia Enriquez-Antonio³, ¹INTERNAL MEDICINE, Hospital Central Sur PEMEX, MEXICO, Mexico, ²Rheumatology Department, Karolinska Universitetssjukhuset, Stockolm, Sweden, ³Internal Medicine, Hospital Central Sur PEMEX, mexico, Mexico
Background/Purpose: HAQ-Di is broadly used to measure disability in RA, its assessment might influence taking decision process. However, it cannot differentiate disability related to arthritis,…
Abstract Number: 333 • 2018 ACR/ARHP Annual Meeting
Electronic Delivery of Patient-Reported Outcome Questionnaires on Tablet PCs at Clinic Visit: A Feasibility Study
Thomas Grader-Beck¹, Michelle Jones², Ana-Maria Orbai² and Clifton O. Bingham III³, ¹Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Assessment of patient-reported outcomes (PROs) at clinic visits has emerged as an important component to determine disease activity in Rheumatoid Arthritis (RA). However, paper-based…
Abstract Number: 334 • 2018 ACR/ARHP Annual Meeting
Use of Handheld Device to Enhance Patient Reported Outcome Measure Data Collection in an Academic Rheumatology Practice
Vivek Nagaraja¹, Vladimir Ognenovski² and Dinesh Khanna¹, ¹Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, ²Department of Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI
Background/Purpose: Patient-reported outcome measures (PROMs) are accepted modalities of gathering patient self-report of their health status in the realms of physical, mental and social well-being.…
Abstract Number: 335 • 2018 ACR/ARHP Annual Meeting
Cross-Cultural Validity of Functional Status Assessment Measures for Rheumatoid Arthritis
Stephanie Kulhawy-Wibe¹, JoAnn Zell^2,3, Kaleb Michaud⁴, Jinoos Yazdany⁵, Linda S. Ehrlich-Jones^6,7, Carter Thorne⁸, Donna Everix⁹ and Claire Barber¹⁰, ¹University of Calgary, Calgary, AB, Canada, ²Denver Health, Denver, CO, ³University of Colorado, Denver, CO, ⁴Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁵University of California, San Francisco, San Francisco, CA, ⁶Shirley Ryan AbilityLab, Chicago, IL, ⁷Northwestern University Feinberg School of Medicine, Chicago, IL, ⁸University of Toronto, Newmarket, ON, Canada, ⁹OnMyCare Home Health, Fremont, CA, ¹⁰Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Background/Purpose: Functional Status Assessment Measures (FSAMs) are important outcome measures in Rheumatoid Arthritis (RA) as poor function is a predictor for mortality and associated with…
Abstract Number: 336 • 2018 ACR/ARHP Annual Meeting
Physical Activity Monitors: New Tool to Assess Improvement in Myositis
Rohit Aggarwal¹, Chester V. Oddis², Siamak Moghadam-Kia³, Diane Koontz⁴, Nicole Marie Neiman³ and Bonny Rockette-Wagner⁵, ¹Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA, ²Division of Rheumatology and Clinical Immunology, Department of Medicine, Unviersity of Pittsburgh/University of Pittsburgh Medical Center, Pittsburgh, PA, ³Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁴Internal Medicine Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁵University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Physical activity monitors (PAM) are increasing being used to objectively quantify free-living movement in clinical research, especially musculoskeletal diseases. Given that patients with idiopathic…
Abstract Number: 337 • 2018 ACR/ARHP Annual Meeting
Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
Savanna Smoker¹, Ellen Romich², Amy Nowacki³ and M. Elaine Husni⁴, ¹Case Western Reserve University, Cleveland, OH, ²Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: RA patients are at about 50% increased risk of cardiovascular disease (CVD)1. Despite this risk, numerous studies show inadequate cardiovascular risk assessment of these…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].